Results 241 to 250 of about 50,545 (304)
Behavioral pharmacology of novel synthetic indazole, indole, and benzimidazole cannabinoids in rodents. [PDF]
Shetty RA +5 more
europepmc +1 more source
Abstract Following an application from Anxiofit Ltd. pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of Hungary, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked for an opinion on the scientific substantiation of a health claim related to Anxiofit‐1 and reduction of subthreshold and mild ...
EFSA Panel on Nutrition +17 more
wiley +1 more source
Advancing cervical cancer treatment: integrating cannabinoids, combination therapies and nanotechnology. [PDF]
Mathibela SP +3 more
europepmc +1 more source
Unraveling Endocannabinoid Signaling Pathways in Cisplatin‐Induced Ototoxicity
We performed a comprehensive molecular profiling of the endocannabinoid (eCB) system (ECS) in an auditory Hair cell (HC)‐like cell line (1). Afterwards, we developed suitable in vitro and in vivo models of cisplatin‐induced ototoxicity where we identified distinct components of the ECS (CB2R, DAGLβ and ABHD6) as molecular targets of the drug (2 ...
Sakthimala Palaniappan +12 more
wiley +1 more source
Targeting the antioxidant, antimicrobial and anti-inflammatory activity of non-psychotropic Cannabis sativa L.: a comparison with chemotype V. [PDF]
Ceresa C +11 more
europepmc +1 more source
Plant Growth-Promoting Rhizobacteria Colonize Δ<sup>9</sup>-Tetrahydrocannabinolic Acid Drug-Type Cannabis sativa L. Roots and Modulate Cannabinoid Metabolism. [PDF]
Tonolo F, Sewalt B, Vrieling K, Choi YH.
europepmc +1 more source
Biotechnological advancements enabling cannabinoid biosynthesis in engineered fungi: a mini review. [PDF]
Manganyi MC +1 more
europepmc +1 more source

